NCT06606184

Brief Summary

The goal of this clinical trial was to access the benefits of a 12-week home-based pulmonary rehabilitation regimen on pulmonary function recovery in post-liver transplant patients. The main questions it aims to answer are: Does pulmonary rehabilitation facilitate pulmonary muscle strength recovery? Does the intervention improve pulmonary function and reduce dyspnea sensation? Participants performed: Inspiratory muscle training twice a day for 12 weeks after discharged from the hospital Upper limb resistive training Lower limb exercise

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 16, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 20, 2024

Completed
Last Updated

September 20, 2024

Status Verified

September 1, 2024

Enrollment Period

2 years

First QC Date

September 16, 2024

Last Update Submit

September 18, 2024

Conditions

Keywords

liver transplantpulmonary rehabilitationinspiratory muscle traininginspiratory muscle strengthDyspnea

Outcome Measures

Primary Outcomes (1)

  • Respiratory Muscle Stregnth Test

    Respiratory muscle strength was determined by Maximum Inspiratory Pressure (MIP) using a pressure monometer.

    Throughout the study completion, approximately 3 month

Secondary Outcomes (3)

  • Oxygenation status

    Participants underwent maximum inspiratory and expiratory pressure measurements at four time points: upon admission, before discharge from the intensive care unit, before discharge from the hospital, and at the end of the 12-week enrollment period.

  • Dyspnea Severity Assessment

    Throughout the study completion, approximately 3 month

  • Forced Vital Capacity

    Throughout the study completion, approximately 3 month

Study Arms (2)

Inspiratory Muscle Training group

EXPERIMENTAL

Participants received a 12-week inspiratory muscle training and incentive spirometry therapy after discharged from hospital

Procedure: Inspiratory muscle Training

Routine care

SHAM COMPARATOR

Participants received incentive spirometry therapy only

Procedure: Routine Care

Interventions

Participants underwent a 12-week program consisting of inspiratory muscle training twice daily, incentive spirometry three times daily, and upper limb exercises along with marching in place for 30 minutes.

Inspiratory Muscle Training group
Routine CarePROCEDURE

Participants received routine care, which included encouragement to use incentive spirometry three times daily.

Routine care

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 20 years or older
  • Scheduled to undergo living donor liver transplantation
  • Stable vital signs
  • Normal cognitive function
  • Able to perform activities independently using their own strength and coordination
  • Willing and able to participate in 12 weeks of rehabilitation training

You may not qualify if:

  • Severe physical illness during the operation
  • Acute bleeding
  • Unstable vital signs
  • Hepatic encephalopathy, or neurological conditions such as stroke, Parkinson\'s disease, or cognitive dysfunction
  • Limited mobility (e.g., unable to stand, lift upper limbs, or bedridden)
  • Inability to comply with 12 weeks of pulmonary rehabilitation post-discharge
  • Unstable vital signs
  • Hepatoencephalopathy, such as cardiovascular accident, Parkinson disease, cognitive dysfunction
  • Those with limited mobility (unable to stand, unable to lift upper limbs, or bedridden)
  • Those who are unable to cooperate with the 12 weeks of pulmonary rehabilitation exercises after discharge.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kaohsiung Chang Gung Memorial Hospital

Kaohsiung City, Taiwan

Location

Related Publications (2)

  • Au KP, Chan SC, Chok KS, Sharr WW, Dai WC, Sin SL, Wong TC, Lo CM. Clinical factors affecting rejection rates in liver transplantation. Hepatobiliary Pancreat Dis Int. 2015 Aug;14(4):367-73. doi: 10.1016/s1499-3872(15)60391-5.

    PMID: 26256080BACKGROUND
  • Aamir,T., Iftikhar,S., Khan, R.R., &Khan, M.K (2019).Role of physiotherapy in improving quality Of life in liver transpant patients. The Rehabilitation Journal, 3(2),126-130.

    BACKGROUND

MeSH Terms

Conditions

Dyspnea

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jui-Fang Lin, PhD

    Chang Gung University of Science and Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 16, 2024

First Posted

September 20, 2024

Study Start

January 1, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

September 20, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

The data is available upon request from the principal investigator.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The data will become available 3 three years after the study is completed.
Access Criteria
The data is available upon request from the principal investigator.

Locations